Status:
COMPLETED
Treatment of Bacterial Vaginosis
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
Pfizer
Conditions:
Bacterial Vaginosis
Eligibility:
FEMALE
16-45 years
Phase:
PHASE4
Brief Summary
We are trying to determine if longer duration of therapy with metronidazole or combination therapy of metronidazole plus azithromycin results in better cure rates for BV
Detailed Description
Bacterial vaginosis (BV) is the most prevalent cause of symptomatic vaginal discharge in the U.S. and has been associated with complications including preterm delivery of infants, pelvic inflammatory ...
Eligibility Criteria
Inclusion
- Symptomatic bacterial vaginosis
Exclusion
- Pregnancy
- Other genital infections
Key Trial Info
Start Date :
July 1 2002
Trial Type :
INTERVENTIONAL
End Date :
May 1 2006
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00324818
Start Date
July 1 2002
End Date
May 1 2006
Last Update
March 1 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jefferson County Department of Health STD Clinic
Birmingham, Alabama, United States, 35294